148 related articles for article (PubMed ID: 33479697)
1. Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis.
Milliken BT; Melegari L; Smith GL; Grohn K; Wolfe AJ; Moody K; Bou-Abdallah F; Doyle RP
RSC Med Chem; 2020 Sep; 11(9):1048-1052. PubMed ID: 33479697
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of acid ceramidase activity by saposin D.
Azuma N; O'Brien JS; Moser HW; Kishimoto Y
Arch Biochem Biophys; 1994 Jun; 311(2):354-7. PubMed ID: 8203897
[TBL] [Abstract][Full Text] [Related]
3. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
5. Structural and membrane-binding properties of saposin D.
Tatti M; Salvioli R; Ciaffoni F; Pucci P; Andolfo A; Amoresano A; Vaccaro AM
Eur J Biochem; 1999 Jul; 263(2):486-94. PubMed ID: 10406958
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
[TBL] [Abstract][Full Text] [Related]
7. Saposin D solubilizes anionic phospholipid-containing membranes.
Ciaffoni F; Salvioli R; Tatti M; Arancia G; Crateri P; Vaccaro AM
J Biol Chem; 2001 Aug; 276(34):31583-9. PubMed ID: 11406625
[TBL] [Abstract][Full Text] [Related]
8. Preferential involvement of both ROS and ceramide in fenretinide-induced apoptosis of HL60 rather than NB4 and U937 cells.
Jiang L; Pan X; Chen Y; Wang K; Du Y; Zhang J
Biochem Biophys Res Commun; 2011 Feb; 405(2):314-8. PubMed ID: 21237137
[TBL] [Abstract][Full Text] [Related]
9. Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR
Thompson D; Mahmood S; Morrice N; Kamli-Salino S; Dekeryte R; Hoffmann PA; Doherty MK; Whitfield PD; Delibegović M; Mody N
Sci Rep; 2023 Mar; 13(1):3937. PubMed ID: 36894641
[TBL] [Abstract][Full Text] [Related]
10. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate.
Yasuo M; Mizuno S; Allegood J; Kraskauskas D; Bogaard HJ; Spiegel S; Voelkel NF
PLoS One; 2013; 8(1):e53927. PubMed ID: 23326540
[TBL] [Abstract][Full Text] [Related]
11. Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans.
Yu H; Valerio M; Bielawski J
J Lipid Res; 2013 Jan; 54(1):189-201. PubMed ID: 23139430
[TBL] [Abstract][Full Text] [Related]
12. Structures of the human ceramide activator protein saposin D.
Popovic K; Privé GG
Acta Crystallogr D Biol Crystallogr; 2008 May; 64(Pt 5):589-94. PubMed ID: 18453694
[TBL] [Abstract][Full Text] [Related]
13. Structure of Human Acid Sphingomyelinase Reveals the Role of the Saposin Domain in Activating Substrate Hydrolysis.
Xiong ZJ; Huang J; Poda G; Pomès R; Privé GG
J Mol Biol; 2016 Jul; 428(15):3026-42. PubMed ID: 27349982
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
16. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Sadeghlar F; Mozcall H; Bernardo K; Schuchman E; Sandhoff K
J Biol Chem; 2001 Feb; 276(8):5760-8. PubMed ID: 11104761
[TBL] [Abstract][Full Text] [Related]
17. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity.
Kim MJ; Jeong H; Krainc D
Hum Mol Genet; 2022 Jul; 31(14):2424-2437. PubMed ID: 35181782
[TBL] [Abstract][Full Text] [Related]
19. Fenretinide mediated retinoic acid receptor signalling and inhibition of ceramide biosynthesis regulates adipogenesis, lipid accumulation, mitochondrial function and nutrient stress signalling in adipocytes and adipose tissue.
Mcilroy GD; Tammireddy SR; Maskrey BH; Grant L; Doherty MK; Watson DG; Delibegović M; Whitfield PD; Mody N
Biochem Pharmacol; 2016 Jan; 100():86-97. PubMed ID: 26592777
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis.
Bikman BT; Guan Y; Shui G; Siddique MM; Holland WL; Kim JY; Fabriàs G; Wenk MR; Summers SA
J Biol Chem; 2012 May; 287(21):17426-17437. PubMed ID: 22474281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
